Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Deroisy

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJ Y Reginster, D Denis, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 20, 1999
Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly womenJ Y Reginster, I Frederick, R Deroisy, et al.
Bone|January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of boneJ Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Lancet (London, England)|February 24, 2001
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialJ Y Reginster, R Deroisy, L C Rovati, et al.
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Plasma concentration of estradiol following transdermal administration of Systen 50 or Menorest 50J Y Reginster, A Albert, R Deroisy, et al.
Maturitas|June 1, 1997
Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50J Y Reginster, A Albert, R Deroisy, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJ Y Reginster, D Denis, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 20, 1999
Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly womenJ Y Reginster, I Frederick, R Deroisy, et al.
Bone|January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of boneJ Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Lancet (London, England)|February 24, 2001
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialJ Y Reginster, R Deroisy, L C Rovati, et al.
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Plasma concentration of estradiol following transdermal administration of Systen 50 or Menorest 50J Y Reginster, A Albert, R Deroisy, et al.
Maturitas|June 1, 1997
Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50J Y Reginster, A Albert, R Deroisy, et al.
Pageof 5